J 2020

Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery

MASKOVA, E., Kateřina KUBOVÁ, B.T. RAIMI-ABRAHAM, D. VLLASALIU, Eva KLÁSKOVÁ et. al.

Základní údaje

Originální název

Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery

Autoři

MASKOVA, E., Kateřina KUBOVÁ (203 Česká republika, domácí), B.T. RAIMI-ABRAHAM, D. VLLASALIU, Eva KLÁSKOVÁ (203 Česká republika), J. TURANEK (garant) a J. MASEK

Vydání

Journal of Controlled Release, Amsterdam, Elsevier Science BV, 2020, 0168-3659

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 9.776

Kód RIV

RIV/00216224:14160/20:00118240

Organizační jednotka

Farmaceutická fakulta

UT WoS

000558614500009

Klíčová slova anglicky

Controlled release; Matrix tablet; Mucoadhesive formulation; Amorphous solid dispersion; 3D printing; Continuous manufacturing

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 5. 2022 14:55, JUDr. Sabina Krejčiříková

Anotace

V originále

Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional pharmaceutical excipient widely exploited in oral sustained drug release matrix systems. The choice of numerous viscosity grades and molecular weights available from different manufacturers provides a great variability in its physical-chemical properties and is a basis for its broad successful application in pharmaceutical research, development, and manufacturing. The excellent mucoadhesive properties of HPMC predetermine its use in oromucosal delivery systems including mucoadhesive tablets and films. HPMC also possesses desirable properties for formulating amorphous solid dispersions increasing the oral bioavailability of poorly soluble drugs. Printability and electrospinnability of HPMC are promising features for its application in 3D printed drug products and nanofiberbased drug delivery systems. Nanoparticle-based formulations are extensively explored as antigen and protein carriers for the formulation of oral vaccines, and oral delivery of biologicals including insulin, respectively. HPMC, being a traditional pharmaceutical excipient, has an irreplaceable role in the development of new pharmaceutical technologies, and new drug products leading to continuous manufacturing processes, and personalized medicine. This review firstly provides information on the physical-chemical properties of HPMC and a comprehensive overview of its application in traditional oral drug formulations. Secondly, this review focuses on the application of HPMC in modern pharmaceutical technologies including spray drying, hot-melt extrusion, 3D printing, nanoprecipitation and electrospinning leading to the formulation of printlets, nanoparticle-, microparticle-, and nanofiber-based delivery systems for oral and oromucosal application. Hypromellose is an excellent excipient for formulation of classical dosage forms and advanced drug delivery systems. New methods of hypromellose processing include spray draying, hot-melt extrusion, 3D printing, and electrospinning.